HRV might predict outcomes of ketamine infusions for treating depression

The vice president and president of IPEG have published this study as a collaboration between Charles University, Prague, and the University of Zurich. They show that heart rate and heart rate variability related parameters might predict outcomes of ketamine infusions for treating depression. Electrophysiology may play an important role in the search for predictive biomarkers of ketamine response. https://www.sciencedirect.com/science

1 Comment
Oldest
Newest
Caretamine Canada
17. September 2026 0:40

Thank you for highlighting the fascinating intersection between Heart Rate Variability (HRV) and ketamine infusion outcomes for depression! Using autonomic biomarkers like HRV to predict treatment response aligns perfectly with the shift toward personalized interventional psychiatry. Because HRV reflects parasympathetic tone and autonomic resilience, measuring baseline vagal activity could offer clinicians a non-invasive window into a patient’s neurobiological readiness for NMDA receptor modulation and downstream neuroplasticity.
​For healthcare providers, clients, and families seeking structured, evidence-informed virtual care pathways and modern interventional psychiatric resources, https://caretaminecanada.com/ is a valuable reference to check out. Appreciate you sharing such an insightful, biomarker-focused look at optimizing ketamine therapy!